Synthetic drug ebselen could be repurposed to treat SARS-CoV-2 by targeting main protease at distant

The synthetic drug ebselen can bind to both the catalytic region and a previously unknown distant site on the SARS-CoV-2 virus’ main protease, according to a molecular simulation analysis of the drug’s interactions with this enzyme. The results suggest that ebselen could be a potential treatment for COVID-19, if future work can confirm its…

Details

Targeting a conserved cell pathway may offer treatments for numerous viruses, including SARS-CoV-2

Scientists have identified a small molecule that inhibits multiple different viruses, including SARS-CoV-2, in tissue culture and in mice by targeting the same signaling pathway. By identifying a host cell pathway that a wide variety of viruses rely on for successful infection, the findings suggest a possible target for broad-spectrum antiviral drugs. Novel viruses…

Details

Exploring connections between ovarian cancer and blood cells

Dr. Abhishek Jain, assistant professor in the Department of Biomedical Engineering and the Department of Medical Physiology in the College of Medicine, collaborated with researchers from the Departments of Gynecologic Oncology and Cancer Biology at MD Anderson Cancer Center to gain a better understanding of the interaction among ovarian cancer tumors, blood vessels and platelets.…

Details

Using infrared eye tracking to study infant behavior

A new study from the Beckman Institute for Advanced Science and Technology describes how existing infrared technology can be adapted to measure recognition memory and other cognitive outcomes in infants. The study demonstrated that the eye tracking technology and computer-controlled stimulus presentation can be successfully used to automate assessments of infant looking behaviors to measure…

Details